CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.92%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
516
New
Increased
Reduced
Closed

Top Buys

1
+$7.38M
2
+$5.53M
3
+$4.72M
4
AVGO icon
Broadcom
AVGO
+$3.5M
5
FUTU icon
Futu Holdings
FUTU
+$3.44M

Top Sells

1
+$2.29M
2
+$2.16M
3
+$2.13M
4
ABT icon
Abbott
ABT
+$2.09M
5
TSM icon
TSMC
TSM
+$2.07M

Sector Composition

1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
201
Chevron
CVX
$350B
$777K 0.06%
5,001
-662
LI icon
202
Li Auto
LI
$16.9B
$760K 0.06%
30,000
+3,000
SYK icon
203
Stryker
SYK
$141B
$741K 0.06%
+2,000
XLY icon
204
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.9B
$723K 0.06%
6,030
TJX icon
205
TJX Companies
TJX
$166B
$718K 0.06%
4,970
JOYY
206
JOYY Inc
JOYY
$3.28B
$715K 0.06%
+12,000
OCUL icon
207
Ocular Therapeutix
OCUL
$1.95B
$707K 0.06%
60,499
-1,496
RBRK icon
208
Rubrik
RBRK
$11.2B
$699K 0.06%
8,500
DXCM icon
209
DexCom
DXCM
$28.5B
$697K 0.06%
10,353
+1,227
KO icon
210
Coca-Cola
KO
$322B
$697K 0.06%
10,431
-3,522
WFC icon
211
Wells Fargo
WFC
$280B
$689K 0.06%
8,215
-2,917
CRNX icon
212
Crinetics Pharmaceuticals
CRNX
$5.12B
$688K 0.06%
16,508
-2,307
NTLA icon
213
Intellia Therapeutics
NTLA
$1.52B
$670K 0.06%
38,816
+18,012
IBM icon
214
IBM
IBM
$287B
$669K 0.06%
2,371
-794
RGEN icon
215
Repligen
RGEN
$8.41B
$668K 0.06%
5,000
+4,885
AKRO
216
DELISTED
Akero Therapeutics
AKRO
$666K 0.06%
14,021
-1,990
ON icon
217
ON Semiconductor
ON
$24.1B
$656K 0.05%
13,297
+1,309
MIRM icon
218
Mirum Pharmaceuticals
MIRM
$6.18B
$646K 0.05%
8,806
-1,143
PM icon
219
Philip Morris
PM
$279B
$644K 0.05%
3,971
-1,341
SUPN icon
220
Supernus Pharmaceuticals
SUPN
$2.76B
$642K 0.05%
13,429
-7,816
ACAD icon
221
Acadia Pharmaceuticals
ACAD
$4.25B
$631K 0.05%
29,573
-4,041
SRRK icon
222
Scholar Rock
SRRK
$4.52B
$627K 0.05%
16,850
-2,219
BEAM icon
223
Beam Therapeutics
BEAM
$2.8B
$625K 0.05%
25,732
+5,535
GS icon
224
Goldman Sachs
GS
$281B
$624K 0.05%
783
-278
ADMA icon
225
ADMA Biologics
ADMA
$4.12B
$613K 0.05%
41,828
-6,121
7 8
9
10 11